全文获取类型
收费全文 | 16807篇 |
免费 | 1083篇 |
国内免费 | 153篇 |
专业分类
耳鼻咽喉 | 207篇 |
儿科学 | 358篇 |
妇产科学 | 170篇 |
基础医学 | 2133篇 |
口腔科学 | 254篇 |
临床医学 | 1269篇 |
内科学 | 4661篇 |
皮肤病学 | 327篇 |
神经病学 | 1114篇 |
特种医学 | 694篇 |
外科学 | 2398篇 |
综合类 | 210篇 |
一般理论 | 21篇 |
预防医学 | 1133篇 |
眼科学 | 374篇 |
药学 | 1034篇 |
中国医学 | 56篇 |
肿瘤学 | 1630篇 |
出版年
2023年 | 93篇 |
2022年 | 66篇 |
2021年 | 260篇 |
2020年 | 251篇 |
2019年 | 355篇 |
2018年 | 396篇 |
2017年 | 369篇 |
2016年 | 418篇 |
2015年 | 477篇 |
2014年 | 595篇 |
2013年 | 722篇 |
2012年 | 1215篇 |
2011年 | 1151篇 |
2010年 | 712篇 |
2009年 | 559篇 |
2008年 | 1094篇 |
2007年 | 1211篇 |
2006年 | 1090篇 |
2005年 | 1122篇 |
2004年 | 982篇 |
2003年 | 1061篇 |
2002年 | 989篇 |
2001年 | 228篇 |
2000年 | 193篇 |
1999年 | 211篇 |
1998年 | 172篇 |
1997年 | 170篇 |
1996年 | 144篇 |
1995年 | 148篇 |
1994年 | 113篇 |
1993年 | 96篇 |
1992年 | 130篇 |
1991年 | 110篇 |
1990年 | 98篇 |
1989年 | 107篇 |
1988年 | 82篇 |
1987年 | 72篇 |
1986年 | 73篇 |
1985年 | 73篇 |
1984年 | 51篇 |
1983年 | 58篇 |
1982年 | 41篇 |
1981年 | 40篇 |
1980年 | 37篇 |
1979年 | 38篇 |
1978年 | 34篇 |
1977年 | 53篇 |
1976年 | 29篇 |
1974年 | 29篇 |
1973年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Azuma Yuka Dohi Osamu Naito Yuji Yasuda Takeshi Yoshida Takuma Ishida Tsugitaka Kitae Hiroaki Matsumura Shinya Doi Toshihumi Hirose Ryohei Inoue Ken Yoshida Naohisa Kamada Kazuhiro Uchiyama Kazuhiko Takagi Tomohisa Ishikawa Takeshi Konishi Hideyuki Nishimura Ayako Kishimoto Mitsuo Itoh Yoshito 《Esophagus》2022,19(2):278-286
Esophagus - This study aimed to evaluate endoscopic findings using non-magnifying blue laser imaging (BLI) to determine the risk factors for metachronous esophageal squamous cell carcinoma (ESCC).... 相似文献
2.
Alzina Koric MPP Chun-Pin Chang PhD Bayarmaa Mark MS Kerry Rowe PhD John Snyder PhD Mark Dodson MD Vikrant G. Deshmukh PhD Michael G. Newman MS Alison M. Fraser MPH Ken R. Smith PhD Ankita P. Date MS Lisa H. Gren PhD Christina A. Porucznik PhD Benjamin A. Haaland PhD N. Lynn Henry MD Mia Hashibe PhD 《Cancer》2022,128(14):2826-2835
3.
Bauermeister José A. Tingler Ryan C. Dominguez Clara Dunne Eileen F. Hoesley Craig Ho Ken Johnson Sherri Lucas Jonathan Macagna Nicole Brown Elizabeth Gundacker Holly Peda Melissa Jacobson Cindy E. Kramzer Lindsay Singh Devika Dezzutti Charlene S. Ayudhya Ratiya Pamela Kunjara Na Marzinke Mark A. Piper Jeanna Devlin Bríd Nuttall Jeremy McGowan Ian Hendrix Craig W. Cranston Ross D. 《AIDS and behavior》2022,26(5):1333-1346
AIDS and Behavior - This study describes the acceptability of a rectal microbicide gel formulation using dapivirine (DPV) among men and women from two countries (United States and Thailand)... 相似文献
4.
5.
Yamadera Masato Shinto Eiji Nagata Ken Shiraishi Takehiro Kajiwara Yoshiki Mochizuki Satsuki Okamoto Koichi Kishi Yoji Ueno Hideki 《International journal of clinical oncology / Japan Society of Clinical Oncology》2022,27(4):756-764
International Journal of Clinical Oncology - In colorectal cancer, tumor budding is highlighted as both a prognostic indicator and a predictor of chemosensitivity. However, tumor budding has a... 相似文献
6.
7.
Hidekazu Iioka Ken Saito Masakiyo Sakaguchi Taro Tachibana Keiichi Homma Eisaku Kondo 《International journal of cancer. Journal international du cancer》2019,145(10):2740-2753
Epithelial cell polarity regulator Crumbs3 (Crb3), a mammalian homolog within the Drosophila Crb gene family, was initially identified as an essential embryonic development factor. It is recently implicated in tumor suppression, though its specific functions are controversial. We here demonstrate that Crb3 strongly promotes tumor invasion and metastasis of human colon adenocarcinoma cells. Crb3 centrality to tumor migration was supported by strong expression at invasive front and metastatic foci of colonic adenocarcinoma of the patient tissues. Accordingly, two different Crb3-knockout (KO) lines, Crb3-KO (Crb3 −/−) DLD-1 and Crb3-KO WiDr from human colonic adenocarcinomas, were generated by the CRISPR-Cas9 system. Crb3-KO DLD-1 cells exhibited loss of cellular mobility in vitro and dramatic suppression of liver metastases in vivo in contrast to the wild type of DLD-1. Unlike DLD-1, Crb3-KO WiDr mobility and metastasis were unaffected, which were similar to wild-type WiDr. Proteome analysis of Crb3-coimmunopreciptated proteins identified different respective fibroblast growth factor receptor (FGFR) isotypes specifically bound to Crb3 isoform a through their intracellular domain. In DLD-1, Crb3 showed membranous localization of FGFR1 leading to its functional activation, whereas Crb3 bound to cytoplasmic FGFR4 in WiDr without FGFR1 expression, leading to cellular growth. Correlative expression between Crb3 and FGFR1 was consistently detected in primary and metastatic colorectal cancer patient tissues. Taking these together, Crb3 critically accelerates cell migration, namely invasion and metastasis of human colon cancers, through specific interaction to FGFR1 on colon cancer cells. 相似文献
8.
Tamami Higuchi Takehiko Yokobori Ryo Takahashi Tomoharu Naito Hiromu Kitahara Takeshi Matsumoto Chihaya Kakinuma Shinji Hagiwara Hiroyuki Kuwano Ken Shirabe Takayuki Asao 《Cancer science》2019,110(9):2933-2940
Chemotherapy has been the treatment of choice for unresectable peritoneal dissemination; however, it is difficult to eradicate such tumors because of poor drug delivery. To solve this issue, we developed FF‐10832 as liposome‐encapsulated gemcitabine to maintain a high concentration of gemcitabine in peritoneal tumors from the circulation and ascites. A syngeneic mouse model of peritoneal dissemination using murine Colon26 cell line was selected to compare the drug efficacy and pharmacokinetics of FF‐10832 with those of gemcitabine. Despite the single intravenous administration, FF‐10832 treatment enabled long‐term survival of the lethal model mice as compared with those treated with gemcitabine. Pharmacokinetic analysis clarified that FF‐10832 could achieve a more effective gemcitabine delivery to peritoneal tumors owing to better stability in the circulation and ascites. The novel liposome‐encapsulated gemcitabine FF‐10832 may be a curative therapeutic tool for cancer patients with unresectable peritoneal dissemination via the effective delivery of gemcitabine to target tumors. 相似文献
9.
Robert J. Marquardt Sung-Min Cho Prateek Thatikunta Abhishek Deshpande Dolora Wisco Ken Uchino 《Journal of stroke and cerebrovascular diseases》2019,28(8):2207-2212
Objectives: To evaluate the safety of acute ischemic stroke (AIS) therapy in patients with infective endocarditis (IE) with intravenous thrombolysis (IVT) or endovascular therapy (EVT) such as mechanical thrombectomy. Methods: We conducted a retrospective study of patients who underwent AIS therapy with IVT or EVT at a tertiary referral center from 2013 to 2017, that were later diagnosed with acute IE as the causative mechanism. We then performed a systematic review of reports of acute ischemic reperfusion therapy in IE since 1995 for their success rates in terms of neurological outcome, and mortality, and their risk of hemorrhagic complication. Results: In the retrospective portion, 8 participants met criteria, of whom 4 received IVT and 4 received EVT. Through systematic review, 24 publications of 32 participants met criteria. Combined, a total of 40 participants were analyzed: 18 received IVT alone, 1 received combined IVT plus EVT, and 21 received EVT alone. IVT compared to EVT were similar in rates of good neurologic outcomes (58% versus 76%, P= .22) and mortality (21% versus 19%, P= .87), but had higher post-therapy intracranial hemorrhage (63% versus 18% [P= .006]). Conclusion: IV thrombolysis has a higher rate of post-therapy intracranial hemorrhage compared to EVT. EVT should be considered as first-line AIS therapy for patients with known, or suspected, IE who present with a large vessel occlusion. 相似文献
10.
Yoshihiro Kanemitsu Ryota Kurokawa Norihisa Takeda Masaya Takemura Kensuke Fukumitsu Takamitsu Asano Jennifer Yap Motohiko Suzuki Satoshi Fukuda Hirotsugu Ohkubo Ken Maeno Yutaka Ito Tetsuya Oguri Akio Niimi 《Allergology international》2019,68(4):478-485
BackgroundWhile gastroesophageal reflux disease (GERD) is one of the commonest causes of subacute/chronic cough along with cough-variant asthma (CVA) and rhinosinusitis, its clinical impact remains unknown. Therefore, we sought to investigate the impact of GERD in patients with subacute/chronic cough.MethodsBetween April 2012 and March 2018, a total of 312 patients presenting subacute or chronic cough lasting for ≥3 weeks [median cough duration, 4.9 (0.7–434) months] underwent diagnostic tests. GERD symptoms and cough-specific QoL were evaluated through the Frequency Scale for Symptoms of Gastroesophageal reflux (FSSG) and the Japanese version of the Leicester Cough Questionnaire (J-LCQ). According to the FSSG domains, patients with GERD were arbitrarily categorized into 3 groups; acid-reflux predominant, dysmotility predominant, and pauci-symptoms groups, respectively.ResultsThe average scores of J-LCQ was 12.5 (SD3.7). One hundred-forty three were diagnosed as having GERD-related cough based on classical reflux symptoms including heartburn and characteristic triggers of cough such as phonation, rinsing, lying, and eating. Most of them (89.8%) had other causative diseases including CVA. Cough lasted longer (p = 0.019) and required a longer time until alleviation (p = 0.003) in patients with GERD than in those without GERD. They also scored lower J-LCQ than counterpart group (p < 0.0001). In terms of symptom stratification, dysmotility predominant group showed significant more response to specific GERD treatments than the remnants (p = 0.002).ConclusionsThese results indicate that GERD is associated with the aggravation of other causes including CVA. Particularly, dysmotility symptoms may be potential therapeutic target for GERD-related cough. 相似文献